about
Infection-Related Focal Segmental Glomerulosclerosis in ChildrenImmunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus modelRNase P Ribozymes Inhibit the Replication of Human Cytomegalovirus by Targeting Essential Viral Capsid ProteinsZika Virus Infects Early- and Midgestation Human Maternal Decidual Tissues, Inducing Distinct Innate Tissue Responses in the Maternal-Fetal InterfaceComparison of Presentation, Course, and Outcome of Congenital and Acquired Cytomegalovirus Infection in TwinsCongenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatmentEngineered RNase P ribozymes effectively inhibit human cytomegalovirus gene expression and replicationRetinal pericytes and cytomegalovirus infectivity: implications for HCMV-induced retinopathy and congenital ocular disease.Valganciclovir for symptomatic congenital cytomegalovirus diseaseCytomegalovirus Infection Triggers the Secretion of the PPARγ Agonists 15-Hydroxyeicosatetraenoic Acid (15-HETE) and 13-Hydroxyoctadecadienoic Acid (13-HODE) in Human Cytotrophoblasts and Placental Cultures.The March towards a Vaccine for Congenital CMV: Rationale and Models.The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection.Symptomatic congenital cytomegalovirus disease following non-primary maternal infection: a retrospective cohort study.Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement.Cytomegalovirus Genotype Distribution Among Congenitally and Postnatally Infected Patients: Association of Particular Glycoprotein (g)B and gN Types With Symptomatic Disease.Combined genetic variants of human cytomegalovirus envelope glycoproteins as congenital infection markersAdenovirus E1A/E1B Transformed Amniotic Fluid Cells Support Human Cytomegalovirus Replication.Comparison of the Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV QuantiFERON Cell-Mediated Immune Assays in CMV-Seropositive and -Seronegative Pregnant and Nonpregnant Women.Advances in the prevention and treatment of congenital cytomegalovirus infectionCytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot Assay but Not CMV QuantiFERON Assay Is a Novel Biomarker To Determine Risk of Congenital CMV Infection in Pregnant Women.Enforced OX40 Stimulation Empowers Booster Vaccines to Induce Effective CD4+ and CD8+ T Cell Responses against Mouse Cytomegalovirus Infection.Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions.Diagnosis and prognosis of congenital CMV infection: a case report and review of the literature.Perinatal outcome after maternal primary cytomegalovirus infection in the first trimester: a practical update and counseling aid.Congenital HCMV and assisted reproduction: Why not use the chance for primary screening?Management and outcomes of cochlear implantation in patients with congenital cytomegalovirus (cCMV)-related deafness.Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.MicroRNA 155 and viral-induced neuroinflammation.Minimal immune determinants connect Zika virus, human Cytomegalovirus, and Toxoplasma gondii to microcephaly-related human proteins.Congenital Human Cytomegalovirus Infection and the Enigma of Maternal Immunity.Fate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets.Cytomegalovirus UL128 homolog mutants that form a pentameric complex produce virus with impaired epithelial and trophoblast cell tropism and altered pathogenicity in the guinea pig.Cytokine gene polymorphism associations with congenital cytomegalovirus infection and sensorineural hearing loss.Encouraging postnatal cytomegalovirus (CMV) screening: the time is NOW for universal screening!Congenital cytomegalovirus related intestinal malrotation: a case report.Analysis of circulating human and viral microRNAs in patients with congenital cytomegalovirus infection.Fifteen-minute consultation: diagnosis and management of congenital CMV.Strong Cell-Mediated Immune Response to Human Cytomegalovirus Is Associated With Increased Risk of Fetal Infection in Primarily Infected Pregnant Women.Hepatic involvement in congenital cytomegalovirus infection - infrequent yet significant.
P2860
Q26746638-ED1243BC-D130-474B-B899-CB81A6BCEE51Q27026924-36478485-29DA-4D6A-9C82-4E38A478DD56Q28646176-E8920FCE-5D8C-47B1-836B-BC58E38B124AQ28733414-7D872A40-F5FD-428A-95AA-40DD870F98E1Q33430388-3230FA28-9EC3-43F1-85CD-DABF07F78464Q33568646-C304010B-749B-4B49-BD7D-C548259DC692Q33820722-C8F29285-9283-4A24-9887-C0778BA8D01DQ35041216-07394A2D-55AE-4D23-A0E5-1A44B987D2ADQ35465712-4DFC8D97-6209-4613-A024-BD791C00641EQ35690401-78B19BFB-5FF1-4ED5-988A-3FDA58B2F545Q35920807-A841BF71-60B6-4890-A746-E8B393A07D70Q36135817-98D4248C-8F9C-4A5A-B237-E39FFEB6B4B6Q36240921-E4E889E0-2527-42AE-85B8-4E3DD1468FA8Q36268583-B67B4B86-8BD8-4E88-A9A9-27F47F514A18Q36286363-D8523C1C-EC3B-4484-AC3C-87D3E061D2DAQ36302015-FA91FA29-3962-4E38-93B1-C519205A4F93Q36325013-672EF042-21A2-4C36-95D6-1153ED2A6BF8Q36645514-53941B0F-1090-4810-92E2-CD3C9584A691Q36834814-3EB6A93D-55F9-4978-93A7-560CFB4977F1Q37006043-A7CD0540-D9C2-416A-BB8C-FF49A99E6177Q37132000-C2291085-9DDA-4BC2-96B9-F1311E0AB854Q37651700-9D02E5FD-1814-4CF9-823A-5C60339F24BEQ38158918-3DC215A2-4537-4741-AB00-AA63385B0F2CQ38235995-D4C10CE0-3A63-4A3A-AF74-5CFB3DB16564Q38249909-F52875F6-2858-4192-8A97-FBBDE2FD5EFEQ38302929-E5E89582-697D-4F30-924C-833D42477EAAQ38796207-7B46936C-43DD-4D2A-9A32-7809F6051C93Q38908361-CC925F9C-B5B7-45E4-86A9-E81BC1316AD0Q39111001-D4A44A9B-F315-4DBF-A4CB-01A152A5FB56Q39160007-F47C6FE2-680B-474E-A309-DD8A117A68B1Q39296561-67CF02E6-B272-4413-8317-11717AE9FB4FQ40086009-A8719855-96AB-4240-8C2F-5C66FFA66F29Q40145257-50A39F71-0D0A-4300-958D-664D0FA2323BQ40202354-85DD290F-C77C-400E-8BFE-33CE978E89F5Q40301048-73E7D465-02A7-4E7D-9BFE-3DFAD75DCDBAQ40421557-5BA7BF40-9693-427A-9FD1-837211F2B2E4Q40522964-DCC20154-4C20-43CD-9F65-2162FD4AF85BQ40698947-B59ADF9B-B94C-4505-8F1C-684E74A94DFBQ41107880-AD9A953D-60B3-4504-9FFB-C1BBF53874FBQ41605395-893016AB-F130-40A9-A5DB-DF8233A46770
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Congenital cytomegalovirus infection: clinical outcome
@ast
Congenital cytomegalovirus infection: clinical outcome
@en
type
label
Congenital cytomegalovirus infection: clinical outcome
@ast
Congenital cytomegalovirus infection: clinical outcome
@en
prefLabel
Congenital cytomegalovirus infection: clinical outcome
@ast
Congenital cytomegalovirus infection: clinical outcome
@en
P2093
P2860
P356
P1476
Congenital cytomegalovirus infection: clinical outcome
@en
P2093
Karen B Fowler
Shannon A Ross
Suresh B Boppana
P2860
P304
P356
10.1093/CID/CIT629
P407
P478
57 Suppl 4
P577
2013-12-01T00:00:00Z